Enzon Pharmaceuticals, Inc.
25
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
52.0%
13 terminated/withdrawn out of 25 trials
40.9%
-45.6% vs industry average
20%
5 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Role: collaborator
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Role: collaborator
Study of EZN-2208 Pediatric Patients With Solid Tumors
Role: lead
A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
Role: lead
Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex
Role: collaborator
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Role: collaborator
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
Role: collaborator
DepoCyt for Active Lymphomatous or Leukemic Meningitis
Role: collaborator
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Role: lead
Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Role: lead
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Role: lead
A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Role: lead
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Role: lead
DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
Role: collaborator
Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage
Role: collaborator
Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
Role: lead
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
Role: lead
A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.
Role: lead
Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma
Role: lead
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02)
Role: lead